Please login to the form below

Not currently logged in
Email:
Password:

AI drug discovery

This page shows the latest AI drug discovery news and features for those working in and with pharma, biotech and healthcare.

Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies

Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies

The companies’ intentions through this collaboration are to accelerate drug discovery and improve clinical access by utilising Exscientia’s existing personalised medicine platform. ... Application of sophisticated AI and machine learning methods will

Latest news

More from news
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • AI and accelerated computing ring in new era for healthcare AI and accelerated computing ring in new era for healthcare

    How AI can reduce drug discovery timelines. Today, we can produce more biomedical data in about three months than the entire 300-year history of healthcare. ... Application frameworks bridge this gap by providing researchers and clinicians the tools for

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    Novartis is investing in artificial intelligence, in alliance with Microsoft, to improve processes, drug design and manufacturing. ... Big data and healthcare. Switzerland is also home to all the major IT companies and both pharma and biotechs are

  • Has AI been the key to tackling the COVID-19 pandemic? Has AI been the key to tackling the COVID-19 pandemic?

    attributes of the drug, they can also uncover whether drugs previously used for other treatments could be an effective cure for this virus. ... UK-based BenevolentAI is just one such company that has used AI and machine learning to aid drug discovery.

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    Drug discovery. AI has the potential to significantly reduce the costs and time associated with drug discovery, across medical divisions and also specifically in handling the immediate COVID threat. ... achieve. Insilico Medicine was able to do this

  • A snapshot of… Exscientia A snapshot of… Exscientia

    As a full stack AI drug discovery company, we generate our own data before combining the analytical power of AI with the creativity and expertise of our world-class scientists. ... However, another key business challenge in the AI drug discovery field is

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...